Instructional Video27:21
Catalyst University

Transfer RNA (tRNA), Codons, and Anticodons

Higher Ed
Transfer RNA (tRNA), Codons, and Anticodons
Instructional Video55:57
Catalyst University

Transcription: Biosynthesis of RNA

Higher Ed
Transcription: Biosynthesis of RNA
Instructional Video7:12
msvgo

Transcription in Eukaryotes

K - 12th
It explains the cellular machinery required for transcription in eukaryotes, including RNA polymerase. It describes initiation, elongation and termination of transcription.
Instructional Video12:38
Catalyst University

The Central Dogma of Biology | Transcription & Translation: The Basics

Higher Ed
This video explores the Central Dogma of Molecular Biology (Transcription & Translation) at an introductory or general biology level.
Instructional Video5:58
Professor Dave Explains

Transcription and Translation: From DNA to Protein

12th - Higher Ed
Ok, so everyone knows that DNA is the genetic code, but what does that mean? How can some little molecule be a code that makes a single cell develop into a giraffe, or a monkey, or Tony Danza? Within this clip lie the answers, child!
Instructional Video5:43
Catalyst University

mRNA Processing: The 5'-7-methylguanosine Cap

Higher Ed
mRNA Processing: The 5'-7-methylguanosine Cap
News Clip3:54
Curated Video

‘This could adversely affect cancer vaccine research’: Experts worry about Kennedy’s mRNA vaccine cuts

Higher Ed
Scripps News speaks with vaccine experts who say HHS funding cuts targeting mRNA vaccines could hinder other vaccine research and development. (Scripps News)
News Clip9:53
Curated Video

RFK Jr. in interview with Scripps News, part 1

Higher Ed
HHS Secretary RFK Jr. sat down with Scripps News for a wide-ranging interview, discussing mRNA vaccine funding policy changes and a recent shooting at the Centers for Disease Control and Prevention. (Scripps News)
News Clip7:12
Curated Video

The U.S. just killed mRNA vaccine funding — what now?

9th - Higher Ed
U.S. Health Secretary Robert F. Kennedy Jr. has cancelled $500 million in funding for the development of mNRA vaccine technology. For The National, CBC’s Heather Hiscox asks infectious disease specialist Dr. Allison McGeer and health...
News Clip1:21
Curated Video

Nobel winners made strides in preventing mRNA degradation

9th - Higher Ed
Dr. Christopher Labos, Montreal-based cardiologist, says mRNA development underlying COVID-19 vaccines was years in the making.
News Clip2:43
Curated Video

How leveraging the power of AI is changing the way Moderna vaccines are made and distributed

9th - Higher Ed
In an exclusive interview with Euronews Next at Cannes Lions, Moderna's chief brand officer sets out why artificial intelligence has been so valuable.
News Clip3:40
Curated Video

Good2Know: Study Shows Promise in Fighting Age-Related Baldness

9th - Higher Ed
A new study from Northwestern University published in the journal PNAS this week suggests that there could be a way to prevent age-related baldness at the cellular level. The study points out that as people age, their hair follicles get...
News Clip1:47
Curated Video

Health Canada authorizes Moderna's bivalent COVID-19 vaccine

9th - Higher Ed
Health Canada's Chief Medical Advisor Dr. Supriya Sharma says Moderna's new bivalent vaccine will target both the old variant of COVID-19 as well as Omicron, the more recent one. It has been approved for use in Canadians 18 years and older.
News Clip1:54
Curated Video

Moderna sues rival COVID-19 vaccine makers Pfizer and BioNTech

9th - Higher Ed
Moderna previously pledged not to enforce COVID-19-related patents but changed its stance as the pandemic shifted gears.
News Clip0:35
Curated Video

Pfizer, BioNTech to Develop mRNA Shingles Vaccine

9th - Higher Ed
Pfizer and BioNTech are working to develop an mRNA-based shingles vaccine following the success of the COVID-19 shot. This latest collaboration will mark the third time the pharmaceutical companies have worked together on a vaccine.
News Clip6:11
Curated Video

What to Make of the CDC's Latest on the J&J COVID Vaccine Going Forward

9th - Higher Ed
The CDC recently endorsed the advisory committee's recommendation that people should receive the Pfizer or Moderna COVID vaccines over the Johnson & Johnson shot, leaving some questions and concerns for the public. Epidemiologist Dr....
News Clip2:14
Curated Video

Infectious diseases doctor and parent shares advice for fellow parents with vaccine questions

9th - Higher Ed
Dr. Alex Wong outlines a few important points about COVID-19 vaccines for parents of younger children.
News Clip7:06
Curated Video

COVID-19: Could Canadians kids be vaccinated by Christmas?

9th - Higher Ed
Ian Hanomansing talks to a virologist and pediatric infectious diseases physician about when Canadian children will get COVID-19 vaccines, parents' concerns and the Johnson & Johnson vaccine.
News Clip3:01
Curated Video

Canada should pursue national strategy on booster vaccines, says specialist

9th - Higher Ed
An agreed national strategy on providing COVID-19 boosters is preferable to the staggered responses of each province, says Toronto respirologist Dr. Samir Gupta.(Credit: Ben Nelms/CBC)
News Clip8:37
Curated Video

3rd dose of mRNA vaccine seemingly quite protective against Omicron, expert says

9th - Higher Ed
Getting a third dose of any mRNA COVID-19 vaccine is an effective way to protect yourself against the Omicron variant, says pediatric infectious diseases specialist Dr. Cora Constantinescu.
News Clip1:15
Curated Video

Mixing the COVID-19 vaccines

9th - Higher Ed
Dr. Isaac Bogoch, a member of Ontario's Vaccine Distribution Task Force, explains why some provinces are already recommending an mRNA vaccine as a second dose following the AstraZeneca-Oxford shot, and why others will likely follow.
News Clip2:09
Curated Video

Champagne announce funding to build mRNA vaccine plant in Ontario

9th - Higher Ed
Prime Minister Justin Trudeau and Innovation Minister François-Philippe Champagne say the government is investing $200-million to build a Mississauga, Ont.-based mRNA vaccine production facility.
News Clip2:09
Curated Video

Trudeau, Champagne announces funding to build mRNA vaccine plant in Ontario

9th - Higher Ed
Prime Minister Justin Trudeau and Innovation Minister François-Philippe Champagne say the government is investing $200-million to build a Mississauga, Ont.-based mRNA vaccine production facility.
News Clip2:10
Curated Video

Moderna VP says mixing vaccines 'is feasible' but warns more clinical data needed

9th - Higher Ed
Moderna vice-president and head of infectious disease research Andrea Carfi tells Power & Politics that mixing the AstraZeneca vaccine with an mRNA dose is possible, but there's not enough data yet to support changing course.